NASDAQ : IRIX
IRIDEX Corporation — Key statistics
Healthcare · Medical Devices · United States
Last price 0.7119 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 12.50M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 12.67M |
| Enterprise Value | 12.01M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 17.56M |
| Shares Outstanding | 17.56M |
| Shares Change (YoY) | +3.35% |
| Shares Change (QoQ) | +0.62% |
| Owned by Insiders (%) | 9.96% |
| Owned by Institutions (%) | 11.90% |
| Float | 10.02M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.25 |
| Forward PS | 0.45 |
| PB Ratio | 3.50 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 0.23 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.82 |
| Quick Ratio | 0.89 |
| Debt / Equity | 1.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -73.15% |
| Return on Assets (ROA) | -5.90% |
| Return on Invested Capital (ROIC) | -18.50% |
| Return on Capital Employed (ROCE) | -19.73% |
| Weighted Average Cost of Capital (WACC) | 5.86% |
| Revenue Per Employee | $554,548 |
| Profits Per Employee | -$38,140 |
| Employee Count | 93 |
| Asset Turnover | 1.75 |
| Inventory Turnover | 3.63 |
Taxes
| Measure | Value |
|---|
| Income Tax | 152,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.63 |
| 52-Week Price Change | -31.29% |
| 50-Day Moving Average | 0.72 |
| 200-Day Moving Average | 1.04 |
| Relative Strength Index (RSI) | 44.67 |
| Average Volume (20 Days) | 1,083,743 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 76,195 |
| Short Previous Month | 131,655 |
| Short % of Shares Out | 0.43% |
| Short % of Float | 0.76% |
| Short Ratio (days to cover) | 0.08 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 51.57M |
| Gross Profit | 18.53M |
| Operating Income | -2.78M |
| Pretax Income | -3.40M |
| Net Income | -3.55M |
| EBITDA | -2.60M |
| EBIT | -2.78M |
| Loss Per Share | -$0.21 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 4.68M |
| Total Debt | 4.01M |
| Net Cash | 667,000 |
| Net Cash Per Share | $0.04 |
| Equity (Book Value) | 3.64M |
| Book Value Per Share | -0.14 |
| Working Capital | 10.79M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -1.73M |
| Capital Expenditures | -270,000 |
| Depreciation & Amortization | 175,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -2.00M |
| FCF Per Share | -$0.11 |
Margins
| Measure | Value |
|---|
| Gross Margin | 35.92% |
| Operating Margin | -5.39% |
| Pretax Margin | -6.58% |
| Profit Margin | -6.88% |
| EBITDA Margin | -5.05% |
| EBIT Margin | -5.39% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -3.35% |
| Shareholder Yield | -3.35% |
| Earnings Yield | -28.51% |
| FCF Yield | -15.70% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 4.44% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -2.3 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |